$191,271,017

UC Davis continues biomedical research using primate models under the ongoing California National Primate Research Center grant, first funded in 1997.

Primate research is irreplaceable for preclinical drug testing and understanding complex human diseases; sustained investment maintains U.S. biomedical research leadership globally.

This research facility generates preclinical data that pharmaceutical companies, biotech startups, and academic labs depend on for drug development pipelines.

China is expanding its primate research capabilities; U.S. leadership in translational biomedical research depends on sustained investment in core research facilities like this.